CHI's Immunogenicity & Bioassay Summit is a premier event designed for professionals in the life sciences, pharmaceutical, and regulatory fields. Scheduled for October 15-18, 2024, at The Watergate Hotel in Washington, D.C., this summit unites industry leaders, academic experts, and regulatory authorities to address critical challenges in immunogenicity and bioassay testing. Attendees can participate in insightful programs including a symposium, workshops, and short courses focusing on topics like immunogenicity assessment, clinical relevance, and bioassay optimization.

The summit features presentations from over ten FDA speakers, case studies showcasing innovative solutions, and interactive breakout sessions to foster collaboration and knowledge sharing. Attendees will also have the opportunity to explore a vibrant exhibit area displaying cutting-edge products and services. Whether engaging with esteemed speakers or networking with peers, participants will gain valuable insights and expertise to navigate the complexities of preclinical and clinical development in biologics. Join us to connect, learn, and advance the field at the #1 immunogenicity and bioassay event in the U.S.